ScreenerHero

XINT Xintela AB (publ)

STO · SE · Healthcare · Biotechnology · xintela.se
0.1660SEK+9.93%Mkt Cap: 12.44M $P/E: —

Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company's stem cell products include XSTEM, which is in Phase I/IIa clinical developmen…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap12.44M USD
Enterprise Value15.21M USD
Revenue (TTM)289.73K USD
Gross Profit218.28K USD
Net Income (TTM)-4.65M USD
Revenue/Share0.0040 SEK
Last Price0.1660 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0007756903
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.50
EV/Revenue52.48
P/S45.49
P/B-5.00
EPS (TTM)-0.06
EPS (Forward)—
52W Range
0.15005% of range0.5000
52W High0.5000 SEK
52W Low0.1500 SEK
Profitability
Gross Margin100.00%
Oper. Margin-735.16%
EBITDA Margin0.00%
Profit Margin-2128.13%
ROE920.99%
ROA-167.32%
Growth
Revenue Growth51.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.98M USD
CapEx (TTM)—
FCF Margin-1762.53%
FCF Yield-41.05%
Net Debt2.02M USD
Net Debt/EBITDA-0.47
Balance Sheet
Debt/Equity-3.79
Current Ratio0.56
Quick Ratio0.54
Book Value/Sh-0.03 SEK
Cash/Share0.04 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.861.27M
Float402.52M
Insiders7.03%
Institutions65.54%
Technical
SMA 500.1747 (-5.0%)
SMA 2000.2308 (-28.1%)
Beta1.91
S&P 52W Chg16.45%
Avg Vol (30d)185.48K
Avg Vol (10d)100.68K
Technical Indicators
RSI (14)37.3
MACD-0.0020
MACD Signal-0.0018
MACD Hist.-0.0003
BB Upper0.1801 SEK
BB Middle0.1651 SEK
BB Lower0.1500 SEK
BB Width18.29%
ATR (14)0.0114 SEK
Vol Ratio (20d)2.15x